APRI Calculator
Use this tool to estimate the AST to Platelet Ratio Index (APRI), a noninvasive score commonly used in liver fibrosis assessment.
APRI = ((AST / AST Upper Limit of Normal) / Platelet Count) × 100
Educational use only. Always interpret APRI with clinical context and professional medical guidance.
What is the APRI score?
The APRI score (AST to Platelet Ratio Index) is a simple calculation that helps estimate the likelihood of liver fibrosis. It uses two standard lab values:
- AST (aspartate aminotransferase), a liver enzyme
- Platelet count, often reduced as liver fibrosis progresses
APRI is popular because it is inexpensive, fast, and based on routine blood tests. It does not replace imaging or biopsy, but it can support risk stratification and follow-up decisions.
How to use this APRI score calculator
Step-by-step
- Enter your measured AST value in U/L.
- Enter the lab’s AST upper limit of normal (ULN). If you are unsure, verify with your lab report.
- Enter platelet count in ×10⁹/L.
- Click Calculate APRI to get your score and interpretation zone.
Correct units matter. Platelets should be entered as ×10⁹/L (for example, 150), not per microliter.
Interpreting APRI results
Cutoffs vary by clinical setting and underlying liver disease, but commonly used thresholds include:
- APRI < 0.5: lower likelihood of significant fibrosis
- 0.5 to 1.5: indeterminate range
- > 1.5: increased likelihood of significant fibrosis
- ≥ 2.0: may suggest higher probability of cirrhosis
These are screening-style cut points, not definitive diagnosis labels. Clinicians often combine APRI with other tools like FIB-4, elastography, and full clinical history.
Why APRI can be useful
- Uses widely available routine labs
- Low cost and easy repeatability over time
- Helpful in settings where advanced imaging is limited
- Can support triage for specialist referral
Limitations and clinical cautions
Important considerations
- AST can rise for reasons unrelated to fibrosis (acute inflammation, muscle injury, alcohol use, medications).
- Platelet counts can be affected by many non-liver conditions.
- Performance differs by disease etiology and population.
- Single measurements are less reliable than trends over time.
APRI should be interpreted as one part of a larger picture, not in isolation.
Who might use an APRI calculator?
- Clinicians in primary care, hepatology, or infectious disease settings
- Researchers screening cohorts for fibrosis risk
- Patients reviewing lab trends and discussing results with their care team
Frequently asked questions
Is APRI the same as a diagnosis?
No. APRI estimates probability and helps guide next steps.
Can APRI replace FibroScan or biopsy?
Generally no. It can complement those methods, especially as an initial noninvasive screen.
Should I use the default ULN of 40 U/L?
Use your laboratory’s reported AST ULN whenever possible, since reference ranges can differ.
Final note
APRI is a practical, evidence-informed tool for liver fibrosis risk assessment. Use it correctly, verify units, and always review the result with a qualified healthcare professional before making medical decisions.